We’re delighted to announce that Avance Clinical will be exhibiting at this year’s ASCO Annual Meeting. Join us at booth #37153 to discover how we partner with innovative biotech companies to advance oncology drug development – from Early Phase through to late-phase global trials.
Over 260 oncology trials conducted in the past five years alone, demonstrating our operational depth and focus on cancer research.
A complete service offering from Phase I/early-phase through to Phase II+ / late-phase, supported by our “GlobalReady” capability spanning Australia, Asia and the United States.
Targeted expertise across a broad range of tumour types including haematological malignancies, solid tumours (NSCLC, melanoma, ovarian, glioblastoma) and rare oncology indications.
Strategic geographic footprint: leveraging Australia’s efficient start-up environment and research rebate ecosystem, expansion into the U.S. for large diverse patient populations, and strong presence in Asia for global enrolment – making us the ideal partner for seamless multi-region oncology programmes.
At ASCO, you’ll have the opportunity to meet key members of our scientific, medical and regulatory affairs, clinical operations and business development teams.
We’d love to schedule time with you at ASCO to discuss your oncology portfolio and how we can support your next milestone. Visit us at Booth #37153, or reach out in advance to set up a dedicated meeting. Book a meeting now.
We look forward to seeing you at the ASCO Annual Meeting — and helping you bring your next oncology therapeutic to the next stage.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com
